1 – 10 of 68
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease
- Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
-
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Pelkmans, Wiesje LU ; Ossenkoppele, Rik LU ; Dicks, Ellen ; Strandberg, Olof LU ; Barkhof, Frederik ; Tijms, Betty M. ; Pereira, Joana B. LU and Hansson, Oskar LU
(2021)
In Alzheimer's Research and Therapy
13(1).
Mark
- Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β–negative cognitively normal individuals
- Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
- Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F]Flortaucipir Studies
- The BIN1 rs744373 Alzheimer's disease risk SNP is associated with faster Aβ-associated tau accumulation and cognitive decline
-
Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
Ossenkoppele, Rik LU ; Reimand, Juhan ; Smith, Ruben LU ; Leuzy, Antoine LU ; Strandberg, Olof LU ; Palmqvist, Sebastian LU
; Stomrud, Erik
LU
; Zetterberg, Henrik
LU
; Scheltens, Philip
and Dage, Jeffrey L.
, et al.
(2021)
In EMBO Molecular Medicine
13(8).
Mark
- A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
- The bvFTD phenocopy syndrome : a case study supported by repeated MRI, [18F]FDG-PET and pathological assessment